Lutronic Announces Abstracts, Podium Presentations and Seminars at Upcoming ASLMS

Lutronic, a leading innovator of aesthetic laser and energy-based technology, announced today a multitude of abstracts, podium presentations, and a symposium panel featuring world-renowned physicians at the upcoming American Society for Laser Medicine & Surgery’s annual meeting in Florida from April 22-26, 2015.

Fremont, California (PRWEB) April 21, 2015

Lutronic, a leading innovator of aesthetic laser and energy-based technology, announced today a multitude of abstracts, podium presentations, and a symposium panel featuring world-renowned physicians at the upcoming American Society for Laser Medicine & Surgery’s annual meeting in Florida from April 22-26, 2015. “We are looking forward to the broad range of clinical presentations that will be given,” says Rich Cohen, Global Clinical Science Officer at Lutronic. “We maintain strong partnerships with leaders in the field of aesthetic medicine in order to further procedure and technology innovation, and are particularly excited by the presentations that will be given on Infini, our leading High Intensity Focused RF device.”

Infini Presentations

Infini will be presented in a ‘PILOT STUDY TO TREAT MILD TO MODERATE LAXITY OF LOWER FACE AND NECK WITH A BIPOLAR FRACTIONATED MICRONEEDLE RADIOFREQUENCY DEVICE’ on April 24th . The abstract discusses the study conducted by Dr. Matteo Clementoni (Istituto Dermatologico,Italy) and Dr. Girish Munavalli (Wake Forest University, USA), in which they explore the effects of RF energy delivered via Infini for the treatment of facial and neck laxity. Infini will also be featured in ‘CLINICAL AND HISTOLOGIC EFFECTS OF HIGH INTENSITY FOCUSED RF IN THE TREATMENT OF PHOTOAGING AND ACNE SCARS’ by Dr. Michael Graves, Dr. Amanda Lloyd, and Dr. E. Victor Ross, all from Scripps Clinic, USA.

Infini Symposium

On the evening of April 24th Lutronic will be sponsoring an ASLMS symposium entitled ‘On Pins & Needles: Exploring the best way to deliver RF energy’, featuring world renowned physicians who will explore the latest innovations in RF energy delivery and why this novel technology is the next ‘must have’ technology for the aesthetic community. The exclusive panel will include Dr. Victor Ross, Dr. Joel Cohen, Dr. Jeremy Green, Dr. Gilly Munavalli, and Dr. Matteo Clementoni.

View Agenda and Register: Lutronic.com/aslms

eCO2 Presentations

Dr. Jill Waibel (Miami Dermatology and Laser Institute, USA) will present on a study that looks at ‘EARLY INTERVENTION OF FRACTIONAL ABLATIVE LASERS FOLLOWED BY 830nm LED PHOTOTHERAPY vs CONTROL FOR ACUTE BURN INJURIES’. Dr. Waibel and Ashley Rudnick summarize their clinical study exploring how using eCO2 combined with Healite II for early scar intervention can make a remarkable difference in the prevention of scar formation. Dr. Waibel will be honored for this abstract with an award at this years ASLMS.

Other Presentations

CLINICAL EVALUATION OF A LARGE SPOT SIZE 800nm DIODE LASER FOR THE TREATMENT OF HYPERTRICHOSIS – Omar Ibrahimi, Connecticut, USA, Christine Dierickx, Boom, Belgium.

Lutronic will also feature their broad array of aesthetic devices in their booth #815 including Infini, Spectra, Clarity (a new dual wavelength Alexandrite and Nd:YAG laser), & eCO2.

About LUTRONIC

Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 17 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, skin resurfacing, body/facial contouring, chronic pain and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 15% of revenues to R&D, Lutronic holds more than 130 current and pending patents worldwide. With more than 250 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, a worldwide network of distributors, and is ever expanding.

For more information about Lutronic and its products, please visit: http://www.lutronic.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/04/prweb12667364.htm